Sequent Scientific Short Term Target

Sequent Scientific formed in 2002 is India”s largest company operating in the animal health sector mainly in API and formulation. For the period March 2020 the company delivered ROE of 11.58% and a ROCE of 12.33% for the quarter of June2020 the company delivered an EBITDA of 32.71 % and Net Profit of 59.98% Net Profit margin stood at 237.17 bps the EPS of the company stood 81.47%.

The company has a market capitalization of 4111.78. We expect the share to hit levels of Rs200 in the next 9-12 months.


Hi i am Samiran Debnath Admin of this website. I am Financial Advisor by profession build client portfolio in stock market and Mutual Fund. I help people to dematerilise physical shares into electronic mode opening demat account. Help clients to choose best insurance policy for them. I love sharing my views on stock market and the benefits investing in SIP and Mutual Funds.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

fifteen + 15 =